Phase
Condition
Tourette's Syndrome
Schizotypal Personality Disorder (Spd)
Mood Disorders
Treatment
SPG302
Placebo
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-65
Primary diagnosis of schizophrenia
Clinical laboratory values within normal range or < 1.5 times ULN
Currently prescribed only one antipsychotic medication, with stable dose for atleast 4 weeks
Able and willing to provide written informed consent
Exclusion
Exclusion Criteria:
Any physical or psychological condition that prohibits study completion
Known cardiac disease
Active or history of malignancy in the past 5 years
History of clinically significant CNS event or diagnosis in the past 5 years.
Receipt of investigational products within 30 days
Blood donation within 30 days
Study Design
Study Description
Connect with a study center
Box Hill Hospital - Eastern Health
Box Hill, Victoria 3128
AustraliaCompleted
Monash
Melbourne, Victoria
AustraliaSite Not Available
Multidisciplinary Alfred Psychiatry Research Centre (MAPrc)
Melbourne, Victoria 3004
AustraliaCompleted
Multidisciplinary Monash Alfred Psychiatry Research Centre
Melbourne, Victoria 3004
AustraliaActive - Recruiting
CenExel CNS
Garden Grove, California 92845
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.